POPULARITY
4 episodes with new guidance
3 episodes with new guidance
6 episodes with new guidance
3 episodes with new guidance
2 episodes with new guidance
2 episodes with new guidance
2 episodes with new guidance
2 episodes with new guidance
2 episodes with new guidance
Lee Brown offers investor insight in the GLP-1 space in what he calls an industry with "expanding opportunity." He believes consumer sentiment has reset to proper expectations following sell-offs in Eli Lilly (LLY) and Novo Nordisk (NVO), anticipating significant upside following the repricing. Tom White offers an example options trade for Eli Lilly.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about
Join us on Discord with Semiconductor Insider, sign up on our website: www.chipstockinvestor.com/membershipSupercharge your analysis with AI! Get 15% of your membership with our special link here: https://fiscal.ai/csi/We discuss Synopsys' recent performance including the most recent quarterly report. The video highlights Synopsys' challenges, including reduced revenue from China, issues with a major foundry customer, and the restructuring of their global headcount. Finally, Nick and Kasey talk about the importance of owning a basket of stocks and what CSI is doing with its portfolio.********************************************************Affiliate links that are sprinkled in throughout this video. If something catches your eye and you decide to buy it, we might earn a little coffee money. Thanks for helping us (Kasey) fuel our caffeine addiction!Content in this video is for general information or entertainment only and is not specific or individual investment advice. Forecasts and information presented may not develop as predicted and there is no guarantee any strategies presented will be successful. All investing involves risk, and you could lose some or all of your principal.Timestamps:(00:00) Overview of Synopsys and Ansys(01:10) Revenue and Free Cash Flow Analysis(02:17) Fiscal Year 2025 Targets(04:01) Challenges and Issues(06:46) Restructuring and Strategic Review(08:01) New Guidance and Future Prospects(11:36) Conclusion and Investment Strategy #synopsys #snps #ansys #anss #edasoftware #semiconductors #chips #investing #stocks #finance #financeeducation #silicon #artificialintelligence #ai #financeeducation #chipstocks #finance #stocks #investing #investor #financeeducation #stockmarket #chipstockinvestor #fablesschipdesign #chipmanufacturing #semiconductormanufacturing #semiconductorstocks Nick and Kasey own shares of Synopsys
With the new guidelines for health practitioners who advertise non-surgical cosmetic procedures coming into effect on the 2nd of September 2025, now is the perfect time to review and reflect upon some of the changes. In this episode of RiskBites Dr Simon Parsons and Dr Colm Harney, dentolegal consultants at Dental Protection discuss the key aspects of this guidance in addition to teasing out some of the important changes in store for practitioners.
In our April edition of risk bites pertaining to Cosmetics in Dentistry, Dr Colm Harney flagged the intention of Ahpra to release new resources and guidelines for registered practitioners undertaking and advertising non-surgical cosmetic procedures.Well, that time is upon us and as of the 2nd of September 2025 the new guidelines will come into effect. Listen is as Colm steps through the key points of interest, in linear order of appearance in the document, so we would encourage you to grab your copy and follow along.
Breast cancer is an hormone responsive malignancy, meaning it may use estrogen and progesterone, reduced in high quantities during a pregnancy, for growth. However, as medical evidence evolves quickly, physicians have come to understand that breast cancer diagnosis during pregnancy doesn't always mean worse prognoses. While older studies- including meta analysis-reflected worse prognoses for pregnancy related breast cancer compared to non-pregnancy related cases, these studies either included studies from the 1960s and 70s when diagnosis and treatment were radically different, had inconsistent definitions of PABC, and/or were poorly age and staged matched. Therefore, as stated in the new UK (Aug 2025) guidance, “the applicability to modern day practice of the findings from these reports is limited”. The more updated clinical stance is that, “By using diagnostic and treatment pathways for women with {pregnancy related breast cancer} which are as close as possible to women with non-pregnancy related breast cancer, similar outcomes can be achieved” (RCOG Green Top recommendations No 12). In this episode, we will summarize key points from the recently released Green Top Guidance No 12 (25 Aug 2025) which has shifted the perspective on treating breast cancer DURING pregnancy. 1. Cubillo A, Morales S, Goñi E, Matute F, Muñoz JL, Pérez-Díaz D, de Santiago J, Rodríguez-Lescure Á. Multidisciplinary consensus on cancer management during pregnancy. Clin Transl Oncol. 2021 Jun;23(6):1054-1066. doi: 10.1007/s12094-020-02491-8. Epub 2020 Nov 16. PMID: 33191439; PMCID: PMC8084770.2. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/pregnancy-and-breast-cancer-green-top-guideline-no-12/3. Sundermann AC, Cate JM, Campbell AK, Dotters-Katz SK, Myers ER, Federspiel JJ. Maternal morbidity and mortality among patients with cancer at time of delivery. Am J Obstet Gynecol. 2023 Sep;229(3):324.e1-324.e7. doi: 10.1016/j.ajog.2023.06.008. Epub 2023 Jun 7. PMID: 37295633; PMCID: PMC10593119.
Today's host was Michael Wear, Founder, President and CEO of the Center for Christianity and Public Life. Thanks for listening to The Morning Five! Please subscribe to and rate The Morning Five on your favorite podcast platform. Learn more about the work of the Center for Christianity and Public Life at www.ccpubliclife.org. Scripture: Hebrews 12 Top Headlines: 1) Trump Administration Issues New Guidelines for Federal Employees on Religious Expression 2) New Study Puts Value of Direct Cash Payments in Doubt 3) Will U.S.-Canada Reach Trade Agreement? Today's host was Michael Wear, Founder, President, and CEO of the Center for Christianity and Public Life. Join the conversation and follow us at: Instagram: @michaelwear, @ccpubliclife Twitter: @MichaelRWear, @ccpubliclife and check out @tsfnetwork Music by: King Sis #politics #faith #prayer #religiousfreedom #TrumpAdmin #Canada #Trade #Tariffs #cashpayments #publicpolicy #poverty Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of The ICHE Podcast, David Calfee joined by three experts who contributed to the development of the updated SHEA guidance on high-level disinfection (HLD) and sterilization: Dr. Emily Sickbert-Bennett, Dr. Audrey Calderwood, and Dr. Erica Shenoy. Together, they bring expertise in infection prevention and hospital epidemiology to a discussion of what's new, what's changed, and how this guidance can be applied in real-world settings. The episode begins by exploring why an update to the 2008 CDC guideline was necessary and how this new document builds upon and clarifies existing practices. The speakers walk through the multi-year process that began in 2018, outlining the rigorous evidence review and unanimous consensus required for each recommendation. They also clarify what was considered out of scope, including topics such as low-level disinfection, environmental cleaning, and access or cost concerns. Listeners will learn how to interpret the guidance within their own institutions, including when no formal recommendation is provided due to insufficient evidence. The episode highlights emerging technologies like disposable scopes, 3D printed devices, and borescopes—discussing which are ready for clinical use and which require further evaluation. To close, each guest offers a practical action item to help listeners improve safety and quality related to HLD and sterilization in their own facilities. This is a must-listen for anyone involved in infection prevention, reprocessing, or clinical safety.
The family of Julio Cesar Chavez Junior speaks out after his immigration arrest. LA's police chief has new guidance for officers dealing with federal agents. Pacoima sees first-hand the deadly potential of fireworks. Plus, more.Support The L.A. Report by donating at LAist.com/join and by visiting https://laist.comVisit www.preppi.com/LAist to receive a FREE Preppi Emergency Kit (with any purchase over $100) and be prepared for the next wildfire, earthquake or emergency! Support the show: https://laist.com
The Bishop Score was originally developed in 1964 by Dr. Edward Bishop and remains the central assessment tool for determining the appropriateness of cervical ripening for labor induction. We have covered pharmacologic and mechanical methods of cervical ripening for labor induction many times in prior episodes. Ut now, in July 2025, there will be a new clinical practice guideline (#9) from the ACOG which has some notable items. Does the ACOG recognize COMBINATION mechanical and pharmacologic agents for cervical ripening for labor induction? What about outpatient cervical ripening? What are the recommended protocols for oral and vaginal prostaglandins? Listen in for details.
In August 2024, the CDC updated its MEC. This included a recommendation for local anesthesia for IUD/S placement and also had guidance regarding misoprostol for that procedure. Coming up in July 2025, the ACOG will officially release a new clinical consensus on “Pain Management for In-Office Uterine and Cervical Procedures”. Are these recommendations similar to the CDC's? What about misoprostol? Was the non-use of local anesthesia for these office-based procedures rooted in racism and sexism? Listen in for details.
In this episode, Jen reviews the EEOC's new guidance regarding “unlawful” DEI programs.
The Trump administration has aimed its cross hairs at yet another group of federal executives, Chief Human Capital Officers. The Office of Personnel Management recommends that agencies designate their CHCOs as general rather than career reserved, and that would open up many human capital leadership positions to becoming political appointments. Here with the latest, Federal News Network's Drew Friedman. Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Trump administration has aimed its cross hairs at yet another group of federal executives, Chief Human Capital Officers. The Office of Personnel Management recommends that agencies designate their CHCOs as general rather than career reserved, and that would open up many human capital leadership positions to becoming political appointments. Here with the latest, Federal News Network's Drew Friedman. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In a "Dear Colleagues" memo, the U.S. Education Department gave schools 14 days to stop using racial preferences as a factor in admissions, financial aid or hiring.
This podcast episode discusses the impact of anti-glaucoma medications on ocular surface health, referencing the latest evidence-based guidelines from the American Optometric Association. It emphasizes the importance of understanding the relationship between glaucoma treatments and ocular surface disease, and the role of optometrists in managing these patients effectively. https://www.aoa.org/practice/clinical-guidelines/clinical-practice-guidelines?sso=y ---------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts Show Sponsors: CooperVision MacuHealth EssilorLuxottica
Host Ericka Adler welcomes back Roetzel Healthcare attorney Christina Kuta for a discussion on the newly updated guidelines from the Illinois Department of Financial and Professional Regulation (IDFPR) regarding the operation and ownership of medical spas. As med spas continue to rise in popularity, the question of who can own and operate one has become increasingly relevant. Christina dives deep into the latest guidance, clarifying the roles of both physicians and nurse practitioners in ownership and operations. Ericka and Christina discuss the provisions of services by licensed and unlicensed persons, collaboration with physicians, the importance of management service organizations, and the crucial requirement for owners to be actively involved in the practice. Highlights include common pitfalls many med spas encounter when entering med spa arrangements, including the potential liabilities for med spa owners. The episode also tackles the unique challenges providers face when treating friends and family, especially in the realm of popular cosmetic services like Botox. Learn why it's essential to treat these individuals just like any other patient and understand the repercussions of not adhering to proper protocols. Finally, Christina discusses the critical infection control measures that must be implemented in both traditional and mobile or home-based services. The conversation concludes by urging listeners to take proactive steps to ensure compliance with the new guidelines, reminding everyone that Illinois-based med spas may now subject to heightened enforcement from the IDFPR, and med spas outside Illinois should make sure they follow the requirements for their states. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
Welcome to the first episode of the #HealthLawHotSpot in 2025! Join host Ericka Adler as she welcomes back Roetzel Healthcare attorney Christina Kuta for a discussion on the newly updated guidelines from the Illinois Department of Financial and Professional Regulation (IDFPR) regarding the operation and ownership of medical spas. As med spas continue to rise in popularity, the question of who can own and operate one has become increasingly relevant. Christina dives deep into the latest guidance, clarifying the roles of both physicians and nurse practitioners in ownership and operations. Ericka and Christina discuss the provisions of services by licensed and unlicensed persons, collaboration with physicians, the importance of management service organizations, and the crucial requirement for owners to be actively involved in the practice. Highlights include common pitfalls many med spas encounter when entering med spa arrangements, including the potential liabilities for med spa owners. The episode also tackles the unique challenges providers face when treating friends and family, especially in the realm of popular cosmetic services like Botox. Learn why it's essential to treat these individuals just like any other patient and understand the repercussions of not adhering to proper protocols. Finally, Christina discusses the critical infection control measures that must be implemented in both traditional and mobile or home-based services. The conversation concludes by urging listeners to take proactive steps to ensure compliance with the new guidelines, reminding everyone that Illinois-based med spas may now subject to heightened enforcement from the IDFPR, and med spas outside Illinois should make sure they follow the requirements for their states.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410 Overview: In this episode, we discuss the latest updates on vitamin D. Learn about its link to common disorders, when to consider supplementation, and what the most recent practice guideline says about vitamin D and disease prevention—empowering you to make informed decisions and improve patient care without unnecessary screenings or treatments. Episode resource links: Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely, Marise Lazaretti-Castro, Paul Lips, Deborah M Mitchell, M Hassan Murad, Shelley Powers, Sudhaker D Rao, Robert Scragg, John A Tayek, Amy M Valent, Judith M E Walsh, Christopher R McCartney, Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 8, August 2024, Pages 1907–1947, https://doi.org/10.1210/clinem/dgae290 Michael F. Holick, Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, Connie M. Weaver, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 7, 1 July 2011, Pages 1911–1930, https://doi.org/10.1210/jc.2011-0385 Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-410 Overview: In this episode, we discuss the latest updates on vitamin D. Learn about its link to common disorders, when to consider supplementation, and what the most recent practice guideline says about vitamin D and disease prevention—empowering you to make informed decisions and improve patient care without unnecessary screenings or treatments. Episode resource links: Marie B Demay, Anastassios G Pittas, Daniel D Bikle, Dima L Diab, Mairead E Kiely, Marise Lazaretti-Castro, Paul Lips, Deborah M Mitchell, M Hassan Murad, Shelley Powers, Sudhaker D Rao, Robert Scragg, John A Tayek, Amy M Valent, Judith M E Walsh, Christopher R McCartney, Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 8, August 2024, Pages 1907–1947, https://doi.org/10.1210/clinem/dgae290 Michael F. Holick, Neil C. Binkley, Heike A. Bischoff-Ferrari, Catherine M. Gordon, David A. Hanley, Robert P. Heaney, M. Hassan Murad, Connie M. Weaver, Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 7, 1 July 2011, Pages 1911–1930, https://doi.org/10.1210/jc.2011-0385 Guest: Jillian Joseph, PA-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
INTO General Secretary John Boyle explains the move is in response to a growing homeless problem
I was out of town and missed this month's Real Estate Commission hearing but a lot of big things happened. The REC released a Guidance Letter on what is considered wholesaling according to the plain language of the statute and how that statute would be applied to advertising that is currently happening in the marketplace. Additionally, I have some updated information on the "Touring Agreement" that was issued and pulled back. Don't forget to like us and share us!Gary* Gary serves on the South Carolina Real Estate Commission as a Commissioner. The opinions expressed herein are his opinions and are not necessarily the opinions of the SC Real Estate Commission. This podcast is not to be considered legal advice. Please consult an attorney in your area.
Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine, Partner, McDermott Will & Emery, about the Department of Justice's (DOJ's) updated compliance program guidance and its implications for Board oversight of compliance. They discuss the DOJ's updated Evaluation of Corporate Compliance Programs guidance, what Boards need to know, and specific considerations for the health care industry.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.
Remember when The Tennis Podcast didn't feature Matt Roberts? No, us neither. But here's a reminder of what we were missing. We did our best with chat about Coco Gauff's Beijing triumph, Karolina Muchova's near miss and the coaching change being sought by Iga Swiatek. Plus, there's a look at the decision to move the Billie Jean King Cup and the Davis Cup back towards home and away ties.Join The Barge!Become a Friend of the Tennis Podcast to also help us to produce the show year-round, receive exclusive access to bonus podcasts throughout 2024, including Tennis Re-Lived and Grand Slam review shows, read Hannah's Column and watch monthly live shows on YouTube. Sign up to receive our free Newsletter (daily at Slams and weekly the rest of the year, featuring Matt's Stat, mascot photos, predictions, and more)Follow us on Instagram (@thetennispodcast)Subscribe to our YouTube channel.Check out our ShopFollow us on Twitter Hosted on Acast. See acast.com/privacy for more information.
On this episode of Dimensions of Diversity, host Lloyd Freeman is joined by colleagues Charlene Barker Gedeus and Mickey Kincade as they explore the latest updates from the Equal Employment Opportunity Commission (EEOC). For the first time in nearly 30 years, the EEOC has updated its enforcement guidance on workplace harassment, bringing significant changes and expansions to existing protections.Charlene and Mickey break down the significant changes in the EEOC's enforcement guidance on workplace harassment, including expanded protections for race, gender, sexual orientation, and religious backgrounds. This episode provides insight for employers on implementing these new guidelines to foster a more inclusive and respectful workplace. More information on the EEOC's guidance can be found here.Dimensions of Diversity is a podcast created by Buchanan Ingersoll & Rooney, highlighting diversity in the workplace. Hosted by Lloyd Freeman, Chief Diversity & Inclusion Officer, the podcast features meaningful conversations with industry and community leaders working to advance D&I.
On this episode, I was joined by Fran Degrazio, President & Principal Consultant at Strategic Parenteral Solutions and Executive Editor at Drug Delivery Leader. On this episode, Fran discusses: 00:00 Introduction 02:29 Understanding the FDA's New Guidance: 05:05 Challenges in Supplier Management and the 08:22 Navigating Change Management 11:43 Insights on Regulatory Compliance 25:26 The Importance of Dimensional Tolerances 32:56 Closing Thoughts Fran DeGrazio is President & Principal Consultant at Strategic Parenteral Solutions and the former Chief Scientific Officer at West Pharmaceuticals. She has been in the pharmaceutical packaging industry for over 35 years with extensive expertise in the area of delivery of injectable drug products, such as vial/closure combinations, pre-fillable syringe systems, and injectable combination products. Throughout her tenure at West, DeGrazio has served in various functions within the analytical laboratory, research and development, and quality assurance/regulatory areas. DeGrazio is an active member of the PDA PMF Visible Particulate Task Force leadership team and the IPAC-RS Materials Working Group. She has also received the Healthcare Business Woman's Association Luminary Award for West Pharmaceutical Services in 2017 and the Philadelphia Business Journal Healthcare Innovators Award in 2018. Frankly Fran Newsletter: https://www.drugdeliveryleader.com/doc/setting-the-bar-for-drug-product-quality-part-the-evolving-practice-of-particle-testing-0001
New South Wales government employees have been advised to return to their on-site workplaces for the majority of their work, shifting away from home-based arrangements. - Naglabas ang NSW government ng isang bagong direktiba na pabalikin ang mga staff ng ibat ibang sektor ng gobyerno sa mga opisina at bawiin ang kasalukuyang hybrid work policy.
Darcie Truttmann, Senior Consulting Actuary for Pinnacle Actuarial Resources, said that new guidance from the American Property Casualty Insurance Association could impact the working relationship between actuaries and auditors.
Earlier this year, new guidelines were released to improve the diagnosis of pediatric sepsis and septic shock. For the first time, the novel Phoenix Sepsis Criteria provides an objective and data-driven approach to aid in the identification of these life-threatening conditions, including prediction of mortality in children with suspected or confirmed infection. Sepsis is one of the leading causes of death among children worldwide, and these guidelines could be a major step in changing outcomes. To help us understand these guidelines and apply them to your practice, we are joined by two experts who have been at the forefront of this new research. Tell Bennett, MD, specializes in pediatric critical care at Children's Hospital Colorado. He is the Vice Chair of Clinical Informatics, as well as a professor of biomedical informatics and pediatrics at the University of Colorado School of Medicine. Halden Scott, MD, is the Director of Research for the section of emergency medicine at Children's Colorado. She is also an associate professor of pediatrics at the University of Colorado School of Medicine. Some highlights from this episode include: How to diagnosis sepsis under the new guidelines How these criteria can be applied to primary care practices What treatment options are and why time is of the essence For more information on Children's Colorado, visit: childrenscolorado.org.
Alex Dunlap, Cody Carpentier and The Trashman talk through the most fragile Wide Receivers to roster in Fantasy FootballTimestamp:0:00 - The RISKIEST WRs to Draft in 2024 Fantasy Football Leagues2:31 - Drake London, Atlanta Falcons6:50 - Garrett Wilson, New York Jets11:44 - New Guidance for Comeback Player of the Year13:00 - Justin Jefferson annnnd/OR Jordan Addison, Minnesota Vikings15:06 - Anthony Richardson's odds to win CPOY17:12 - Michael Pittman Jr., Indianapolis Colts20:11 - George Pickens, Pittsburgh Steelers22:17 - Is Brandon Aiyuk worth $27 Million?26:23 - Give me Malik Nabers's stat line, today27:13 - Zeke Elliott is worth the squeeze28:30 - Very concerned about the Round 2 Wide ReceiversJoin RosterWatch Nation TODAY!!Go PREMIUM for Weekly Rankings and DFS Tool -- https://rosterwatch.com/buy-rosterwatchFollow us on Twitter -- https://www.x.com/RosterWatch Follow on Instagram -- https://www.instagram.com/rosterwatch/----------------RosterWatch is your year-round source for the best Fantasy Football analysis, including updates LIVE from Training Camp, The NFL Combine, Pro Days, and the Senior Bowl and Shrine Bowl.----------------Subscribe to the podcast:iTunes -- https://podcasts.apple.com/us/podcast/rosterwatch-podcast/id493875129?mt=2Spotify -- https://open.spotify.com/show/2jWDOZcppg9uYVaAWA7YdM?si=0b9aeaa77ae24316&nd=1&dlsi=1b5923c3f21b43c7iHeartRadio -- https://www.iheart.com/podcast/269-rosterwatch-podcast-48874884/RosterWatch PRO offers the best toolset available to help you win your fantasy football league. What is RW PRO?* A full season of fantasy football power tools designed to make winning easy and fun.* Year-round NFL player analysis.* Exclusive live off-season coverage from all major NFL scouting events.Support this podcast at — https://redcircle.com/rosterwatch-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Today Pastor Stan continues to talk about the Petrodollar’s dusk and Petroyuan’s Dawn! In other news, Russia is ready to strike NATO Airfields, Germany update their Wartime Measures and we see that Biden signs “New Guidance” for using U.S. Nuclear Weapons. 00:00 - Leslie’s Prophecies 02:10 - PetroYuan & Wealth Transfer 08:04 - Fall of America 09:54 - Joseph’s Kitchen 13:02 - Death of Dollar 18:10 - Russia Ready to Strike NATO 20:56 - New Guidance for using Nuclear Weapons 24:00 - Israeli Troops Uncover Hamas Tunnel 25:52 - Our Sponsors
Today Pastor Stan continues to talk about the Petrodollar’s dusk and Petroyuan’s Dawn! In other news, Russia is ready to strike NATO Airfields, Germany update their Wartime Measures and we see that Biden signs “New Guidance” for using U.S. Nuclear Weapons. 00:00 - Leslie’s Prophecies 02:10 - PetroYuan & Wealth Transfer 08:04 - Fall of America 09:54 - Joseph’s Kitchen 13:02 - Death of Dollar 18:10 - Russia Ready to Strike NATO 20:56 - New Guidance for using Nuclear Weapons 24:00 - Israeli Troops Uncover Hamas Tunnel 25:52 - Our Sponsors
In this episode of The Consumer Finance Podcast, Chris Willis is joined by Troutman Pepper Partner Lori Sommerfield to discuss the new guidance issued by the Department of Housing and Urban Development (HUD) on targeted advertising for housing and housing-related ads. The conversation delves into the implications of the guidance, which was motivated by HUD's original charge of discrimination against Facebook in 2019 and President Biden's 2023 Executive Order on the Safe, Secure, and Trustworthy Development and Use of AI. They explore how the guidance shifts the focus from disparate treatment to disparate impact, and the challenges advertisers and advertising platforms may face in complying with the new guidelines. The episode concludes with a discussion on the potential for regulatory overreach and the possibility of litigation.
Campus protests are continuing to intensify across the country, prompting university officials to now warn students about potential bans and suspensions from school. Also, pediatrician and Co-Director of the “American Academy of Pediatrics,” Dr. Jenny Radeski, offers new guidance on screen time and social media for kids of all ages. Plus, Craig Melvin shares the inspiring story of a man with Parkinson's disease and his rock-climbing instructor who are giving many people with the condition hope. And, TODAY contributor Ally Love shares some D.I.Y. tips and tricks on how to rejuvenate your mind, body, and soul.
Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Learn more about your ad choices. Visit megaphone.fm/adchoices
THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 MOP Ladies aka the Missouri Precinct Project | Send an email to the MissouriPrecinctProject@gmail.com | Another congressperson is retiring this year 18:03 SEG 2 ZACK SMITH, Legal Fellow at The Heritage Foundation and Co-host of the SCOTUS 101 Podcast, talks about whether Trump can be held in contempt of court | His bond being lowered | mifepristone | Tipping the Scales of Justice to the Left? The Federal Judiciary's New ‘Guidance' for Assigning Cases | Julian Assange https://twitter.com/tzsmith https://www.heritage.org/staff/zack-smith 33:51 SEG 3 Joe Lieberman passed away at age 82 today CHRIS' CORNER https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/newstalkstlstream RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.
THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 MOP Ladies aka the Missouri Precinct Project | Send an email to the MissouriPrecinctProject@gmail.com | Another congressperson is retiring this year 18:03 SEG 2 ZACK SMITH, Legal Fellow at The Heritage Foundation and Co-host of the SCOTUS 101 Podcast, talks about whether Trump can be held in contempt of court | His bond being lowered | mifepristone | Tipping the Scales of Justice to the Left? The Federal Judiciary's New ‘Guidance' for Assigning Cases | Julian Assange https://twitter.com/tzsmith https://www.heritage.org/staff/zack-smith 33:51 SEG 3 Joe Lieberman passed away at age 82 today CHRIS' CORNER https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/newstalkstlstream RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.
You can do this! Hear from the government lawyers who review the new student loan discharge forms on behalf of the Department of Education as well as the lawyers that prepare the forms on behalf of debtors. This presentation will discuss the process for discharging student loans in light of new guidance issued by the Department of Justice in coordination with the Department of Education. The presentation will review step-by-step instructions for completing the new required form and supporting documents intended to streamline the fact-gathering process. The presentation will also discuss how counsel can identify cases in which the government may stipulate to facts demonstrating undue hardship. The discussion will be moderated by Grace Brockmeyer, Bankruptcy and Consumer Staff Attorney at the Volunteer Lawyers Project, and the panelists are Steffani Pelton of Madoff & Khoury LLP, and Brendan Mockler and Raquelle Kaye, Assistant United States Attorneys in the Asset Recovery Unit who handle bankruptcy litigation on behalf of the United States. Questions? Inquiries about program materials? Contact Trenon Browne at tbrowne@bostonbar.org
Keller and Heckman Partner Manesh Rath hosts OSHA 30/30, a webinar series that covers OSHA issues for 30 minutes every 30 days. Mr. Rath is a trial and appellate attorney with experience in general commercial litigation, wage and hour and class action litigation, occupational safety and health (OSHA) law, labor law, and employment law. This month's topic: OSHA Released New Guidance on the PSM Standard. How Could This Affect You?
In this episode, Ken Hoyme, a semi-retired product security expert, talks in-depth about his 40-year career focusing on safety-critical systems, which spanned across commercial aviation, aerospace, and medical devices, with a particular focus on medical device security. Ken reflects on the personal impact of his work, and also talks about his continued involvement in the field through consulting, teaching, and volunteering post-retirement. He also discusses troubleshooting solutions, his pride for his family, and his passion for pipe organs. Guest links: https://www.linkedin.com/in/kenhoyme/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com. PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium EPISODE TRANSCRIPT Episode 022 - Ken Hoyme [00:00:00] Lindsey Dinneen: [00:00:01] Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:08] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:13] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:27] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:37] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:41] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. [00:00:47] Hello and welcome to The Leading Difference podcast. I'm your host, Lindsey, and I am excited to introduce you to my guest today, Ken Hoyme. Ken is the semi retired former Director of Product security at Boston Scientific. His 40 year career spanned commercial aviation and aerospace and medical devices with specific emphasis on medical device security. In retirement, Ken continues to consult, teach, and volunteer. Welcome, Ken. Thank you so much for joining us today. I'm so excited that you're here. [00:01:20] Ken Hoyme: Thanks, Lindsey I'm happy to be here. [00:01:22] Lindsey Dinneen: Wonderful. If you wouldn't mind just starting off by telling us a little bit about yourself and your background, I would love to hear more about you. [00:01:31] Ken Hoyme: Sure, I'd be happy to. Being semi retired, I have had a career that spans close to 40 years, or actually I think I just passed 40 years about a month ago from when I started working. So I went to grad school, did four years of grad school at the same time my wife was in vet school, so four years of marriage that we were both studying like crazy. I never finished my dissertation on a PhD, so I'm the classic PhD, ADD person. Pretty much my entire career has been spent in safety critical, life critical systems, which has been a fascinating area. You gotta do the right job or people might die. [00:02:08] I started, split 50 /50. My first 18 years was at Honeywell Corporate Research Labs, where I ended up working on various things between integrated circuit projects, but a lot of it was focused on control systems for commercial aircraft, and so building safety critical systems that made the pilot interface to the airplane was fascinating, tough, but interesting problems. [00:02:32] Touched a bit on industrial controls and automotive controls, and then mid career, I got recruited away by former Honeywell folks who had gone to Guidant, medical device company at the time, that was later purchased by Boston Scientific, and where I ended up working initially on cardiac pacemakers and defibrillators and then shifted into remote patient monitoring, and that kind of evolved into more detailed interactions with how security can impact patient safety. [00:03:02] So a large fraction of the last 12, 15 years has been in medical device cybersecurity. Did a brief stint, three and a half years, at a small R&D company doing research on medical device cybersecurity, and then returned to Boston Scientific in 2016 to lead the product security program at Boston Scientific, which is what I was doing when I officially retired. [00:03:25] Lindsey Dinneen: Nice. Okay. So lots of cool twists and turns throughout your career. I wanted to touch on a couple things. The first is, you've actually talked about how one of the running themes was safety and safety critical systems and whatnot. And I'm curious, have you always had an interest or a passion in safety and security. Where did that come from? [00:03:49] Ken Hoyme: Given some of my behavior as a kid, you wouldn't think so. I certainly did my share of foolish things as you grew up. My, my interest in grad school was in computer architecture, kind of a foot between hardware and software, though I was in electrical engineering as a degree. So as I ended up at Honeywell, Honeywell was at that time focused on control systems. And control systems are cyber physical systems, they are computers touching the real world physically. And almost all aspects of cyber physical systems-- which are pervasive and now what's viewed as US critical infrastructure-- there's a safety aspect of whether you're talking about nuclear power plants or oil refining and things that can explode to commercial aviation, automotive. All of those things, if they don't work correctly, the people that are interacting with them that run the risk of being harmed. [00:04:44] So it really was that culture at the original research center of thinking about how you interact with the physical world. And so that really grew that interest. And that was the skill set in doing safety analysis that drew guidance to recruit me because it really was obviously another safety critical environment in cardiac devices. So it was a an early budding interest that was really nurtured by the projects and things that worked on for Honeywell. [00:05:14] Lindsey Dinneen: Yeah, absolutely. And then you obviously continued to grow in your career, you continue to be involved in safety and security. And then you had your stint at Boston Scientific. And I wonder if you could share a little bit more about some of the projects that you worked on that were particularly impactful or just moments that stand out perhaps. [00:05:36] Ken Hoyme: My first project, I knew nothing about things that bled. I had avoided them. In junior high, I had to dissect a frog, I really didn't like it. And so in high school, when you needed to have some science stuff, and I knew I was planning on going toward electrical engineering, I skipped biology and took chemistry and physics. And by working on cyber physical systems, aircraft and automotive and industrial controls, nothing bled, but I also had no pets growing up. [00:06:09] And when I started dating my now wife of 44 years, she had a quarter horse, 4 Shetland ponies, a dog and two cats at a 10 acre hobby farm she had talked her parents into buying so that she could have horses. And as a veterinarian, everything in her life bled, so we really had this difference in backgrounds, but interest in learning from each other. [00:06:35] And so when I first went to Guidant, the company recognized I didn't have that domain knowledge. And so I ended up being put on projects specifically with the goal of rapidly bringing me up to speed. I went to various classes on how the heart works, how you pace it, all the various different things. And I can tell you that the dinner conversation changed considerably as I was starting to learn these things and my wife knew these things. So it was kind of an exhilarating mid career change because of having to learn the domain. [00:07:05] So, because of my safety background, Guidant was working on a new architecture for their pacemakers and defibrillators. And I got put on the redundant safety core, which was a redundant hardware pacemaker and defibrillator. If anything failed in the rest of the device, the hardware would kick in and keep the patient pink. And so I got to work on that, and I ended up with several patents. [00:07:30] And so in 2006 or 7, I believe, my brother in law, my wife's brother, ended up with a viral cardiomyopathy and his ejection fraction was down at 15%. It's normally in a healthy human should be up around 70. He ended up getting a resynchronization defibrillator that I had worked on, as well as being put on the home patient monitor that I had been the lead system engineer in developing. And so that was that first family connection of recognizing that what you're doing is personal. [00:08:04] And a few years back, my now 95 year old mother in law has a pacemaker in her and I have four patents on the technology. So you're recognizing that people that you love and care for are using these things. And the people who get these things are loved and cared for by somebody, so it really becomes a passion of building something that works correctly and is safe. Those kind of things stand out in terms of things that are meaningful. [00:08:29] Lindsey Dinneen: Yeah, of course. Yeah, because when you are able to see the results in real time in real life, by people who you know personally who are affected by it, that's such a full circle moment of just recognizing that what you do isn't confined to this silo. It actually does impact lives. And that's a pretty cool thing to be a part of. [00:08:52] Ken Hoyme: And I crossed over into security. I can recommend the devices that I was involved in developing because I am personally familiar with the level of detail that had been done in terms of securing them. So I don't have fears that my family members or others are going to have hackers going after them, which is a paranoia in the industry. The idea of hacking pacemakers became, as Dr. Kevin said, " sucks the oxygen out of the room." It's theoretically possible, but very difficult to do, compared to devices that might be connected to a hospital network, which are exposed to more. [00:09:24] Lindsey Dinneen: And to that point, if you don't mind sharing a little bit more about how you were able to develop those skills and awareness of the importance of medical device security. I know that you are an expert in this field and there is a lot more education and knowledge these days, but it still seems like something every once in a while that you have to remind people, this is actually a critical thing. Do you mind speaking a bit to that? [00:09:52] Ken Hoyme: I started out as an electrical engineer, but evolved to a systems engineer, particularly working in aviation. I worked on the design of the flight deck of the Boeing 777. And Boeing is the-- at least they used to be, they've lost some of the secret sauce-- but they were the premier system engineering organization in the world. And working on a critical system for an aircraft with the master of system engineering, you start learning the techniques. So my, my evolution into system engineering was very much on the job training, certainly a lot of reading and things that went on at the same time, but it was also interacting with experts. [00:10:31] Similar thing happened when security came along is, I got recruited into Guident because of my safety skills. And then within the first year of being there, Guident was putting a remote patient management system together, which was a bedside monitor for every patient with the radio links to the device links up to a server that would analyze all the data for potential alerts that the physician should know. [00:10:56] The system has more than a million patients on it. So it's a scalable protected health information, all of that. Program Manager on that project understood the importance of the various ilities that sit around system engineering and deal with the development. So he hired in a PhD psychologist to do human centered design and machine interface, he had been dealing with all of those issues. And in the medical device world, user interfaces also touch safety, because if you have confusion and a physician or patient makes a mistake in using something, harm can happen. So it's another branch of safety. And he recognized the security implications of what we were doing and hired in security experts. [00:11:43] And so we had this old grizzled, bearded, absolutely canonical look of a computer geek that had been a chief architect at a company called Secure Computing and had been security. And he was titled our Security Curmudgeon and as Lead System Engineer, I worked with these various groups as we balance the design. And it really was interacting with real experts in this field who had no compunction about correcting me whenever I said anything that was inaccurate. [00:12:15] In that environment, I started absorbing. The methods of doing security and the importance of it and what those kind of, so it really was one of those cool opportunities in your career where you get to a Vulcan mind meld with experts and absorb the information and integrate it with what you know. [00:12:32] Lindsey Dinneen: Yeah, absolutely. And at the time of this recording the FDA has finalized their guidance and I'm curious to know what your thoughts are on that and how you feel it's going to affect everybody moving forward. [00:12:50] Ken Hoyme: It's interesting because both the original pre market guidance and the post market guidance came out relatively quickly. The time between the draft pre market and the issuance of it, I think was just less than a year, which everyone who were involved with guidance has said was light speed for the FDA. And the post market was similar, but they've done a couple of iterations in 2018 and 2022 of drafts. And, was in a meeting earlier today where two of the FDA people who had been working on that were mentioning that in both cases, they got more than 100, 000 comments back to the FDA related to it. [00:13:28] You know, the push by Congress to have it out by October 1st really pushed, I don't think anybody thought that it would be feasible to get it done. And yet they did it. It seems like they have clarified many of the concerns that were still in the 2022 draft, had some clear definitions about things like exploitability. So I think it really will anchor, and everyone is scrambling this week to read it and adapt to what's in there. But, the good news is it's not a giant leap from what they issued in 2022. So it's not going to have everyone doing a 90 or 180 degree turn on what they've already assumed it was heading for. So it's just good to have that out in its definitive form. [00:14:14] Lindsey Dinneen: Yeah, absolutely. And it'll be exciting to see how the industry adapts. [00:14:19] Ken Hoyme: As one example, the Health Sector Coordinating Council had published in 2018, I believe it was, their joint security plan, because the non formal standard, but kind of a guide, particularly helpful for smaller companies for what they need to do, incorporate cybersecurity into their quality system and their development. And a lot has changed, and so we have been working since middle of 2022, this is one of my retirement volunteer efforts that I'm involved in, to bring it up to date. [00:14:54] And there was a real goal for the JSB version 2 to be out by the end of this year. And we were worried about the race condition with the FDA getting their final set pre market guidance out. And so one of the activities now is adapting what we've written in the joint security plan to make sure that it is in sync and in line with the finalized guidance. By getting it out now, we have time over the next couple of months to make whatever changes we need to based on that change. Which will be good, it means when that guide is updated, it will not be anchored in an old guidance, but will properly reflect the new update from the FDA. So it's really great to see them do that. [00:15:38] Lindsey Dinneen: Yeah, absolutely. So circling back to something you mentioned, because I'm curious how you were able to overcome it. You mentioned you hadn't dealt early on in your career with anything blood related and you didn't necessarily want to go after that when you were in college. So how are you able to overcome that and say, "No, this is fine. I'm gonna, I'm gonna make it happen." [00:16:05] Ken Hoyme: Thankfully, I didn't have to personally do any implants. Okay. I didn't have to handle a knife or deal with that and get flashbacks of my frog experience. When I left Honeywell, I thought I was going to retire out of the company. I was in an absolutely great position at the research center. I was invited to the strategic planning sessions for the entire aviation business as a technical expert. Honeywell was bought by Allied Signal, which was quite a culture shift. They were far more prescriptive. You're telling research center, here's what you're going to do rather than asking you to partner with the businesses, determine how to best apply the skills. And the other aspect is because I had become an expert in commercial aviation, I was not learning at the rate that you used to. It's like, you know, a lot of things, you're doing more mentoring than individual personal learning. So when I shifted domains and got hired in because I was a senior fellow at Honeywell, they hired me in at the top technical rank that Guidant had at the time to be competitive. I felt a huge obligation to learn the domain as quick as possible. [00:17:19] I needed to feel like I was providing value. It's just not a good feeling to feel like you're taking a paycheck and not providing something for that. It's just not the way I was raised. And so I really took it on that I needed to learn this domain. And the reality, all kidding aside, is the work in understanding the physiology and the behavior of cardiac devices is really more about electrochemistry and how the muscles work and how arrhythmias occur and how they can be cleared. And so it was more of a learning a new technical domain than really dealing with the bleeding side of it. [00:17:57] Yes, when I was at Honeywell, we had a program where if we were working in the commercial aviation side, we had, it was pre 9/ 11, we had jump seat privileges. So I got to be in the jump seat of aircraft so that you could see how the pilots who use the systems you develop, how they interact with them, just as an experience base. And one of my cool things, just as an aside to talk about, along with the family members using cardiac devices is, I got to jump seat a 777 from Dulles to Frankfort, and that's the aircraft that I did a fundamental invention to enable how the flight deck works. So that was cool to actually see the pilots interact with what you did. [00:18:39] The same thing happened in the cardiac world is you got the opportunity to go and experience implants and see the doctors using and interacting with the devices. Again, part of that system's knowledge of how does the end person, the actual user, use those devices and how do you use that knowledge to get better. So the closest thing you get to bleeding is to watch somebody else do one but I never had to actually directly deal with blood. [00:19:10] Lindsey Dinneen: Okay. That's fair. That's a really good hybrid situation right there. Well, nowadays I understand that you are quote unquote retired, however, you are still quite active. So I would love to hear about your current initiatives and frankly, if you don't mind sharing, why you're still so involved, obviously you care, but I'd love to hear it from your perspective. [00:19:35] Ken Hoyme: So I've always been a bit of a workaholic. I gained a lot of my intellectual stimulation through the people I interact with. When I started a corperate research center, it was 25% PhDs, 50% master. It's a great learning environment because there were brilliant people are all around you. [00:19:52] One of my career advices I've given to the young people is go to a place where you are not the smartest person in the room, surround yourself with people you can learn from. Now you want to have your niche. You want to have something that you feel is your area of expertise that you build, but being or thinking you're the best person in the room isn't necessarily a good learning experience. So, I've always enjoyed interacting with people at various stages in their career. [00:20:20] So when I retired, I don't know how many different serious and semi serious reach outs I had from people asking what I was up to and what I was interested in. It was a dozen or something, but I had been interacting for several years at the company called MedCrypt out of San Diego, a company that focuses on initially tools to help secure medical devices, comes out of the medical device world and tools for software build of materials, things of that nature. And while I'm not a software engineer developing tools, they were also starting to build a service business to work with clients on how to improve their quality system. [00:20:59] When I was at Adventium Labs, that three and a half year stint I did between my two Boston Scientific experiences, along with doing government funded research on medical device security, I also did consulting with companies, and so I had formed a reasonably strong opinion about how you can best organize cybersecurity into a quality management system in a medical device company. And so being able to apply those skills, very lightweight, I've tried to keep my consulting to no more than one day a week so that I still can do some retirement activities. [00:21:36] And Mike Kijewski, who's the CEO of that, I've interacted with him for many years and he had been pursuing me before I retired. So they have some people on staff, two of them are ex FDA. One of their FDA people, Seth Carmody, had written the post market cybersecurity for the FDA and I think he did the first draft of the updated cybersecurity pre market. And then they have another gentleman, Axel Wirth, who I've interacted with for a decade and has written textbooks in the space. And so it was a way to continue where you got to really work with smart people and continue to have that intellectual stimulation that watching TV or picking up whittling doesn't give you. [00:22:16] Lindsey Dinneen: Fair, but those two activities on occasion could be good for your mental health, which we were talking about. So you can have both. You can have both. [00:22:26] Ken Hoyme: So my eldest daughter, when she was going through undergrad, wanted to take a class. She went to Luther College in Iowa, which was a very Scandinavian Norwegian school, and there was a class on Scandinavian whittling. And she really wanted to take it, and she did, but she was going into dental school, and so there was this paranoia about her slicing something important in her hand when she was whittling. She whittled with Kevlar gloves on! [00:22:54] Lindsey Dinneen: Oh! [00:22:55] Ken Hoyme: So there's a certain amount of connection, potentially, between whittling as a hobby and that blood thing that I didn't like, so that hasn't necessarily attracted me retirement hobby. [00:23:04] Lindsey Dinneen: That's a fantastic story. I love that. I wonder, you know, with her whittling skills, did those help her in her dental practice? [00:23:12] Ken Hoyme: She stopped it after undergrad. She also no longer plays the oboe, though she had an oboe scholarship along with her sciences because the finger stretching on the oboe ,she has all of the finger exercises she gets at work and doesn't really think she should be taking the risk of fatiguing it more. And so yeah, being safe in that environment has been important. So I think the thing that actually did the best for her is playing video games. She played things like Mario World, where you're having to constantly in your brain translate going around sphere things and jumping. And that's when you're looking through a mirror and drilling in the back of the mouth, you're constantly doing these translations. And so I'm convinced that all the video games she played growing up really gave her the spatial skills that help, particularly as she took the exams to get in, they do try to assess whether somebody is capable of that before you get into dental school, because you don't want to get in there and start getting into drilling and having somebody who just can't make their brain do that. [00:24:17] Lindsey Dinneen: Thank goodness. [00:24:19] Ken Hoyme: Exactly. [00:24:20] Lindsey Dinneen: That's fantastic. [00:24:21] Ken Hoyme: No wonder why people are afraid of the dentist. Maybe they had one of the bad ones. [00:24:25] Lindsey Dinneen: Right. Yeah, exactly. Oh, my goodness. Oh. [00:24:28] Ken Hoyme: And then I had already alluded to the fact that I'm, I'm doing volunteer work at HSCC on the joint security plan. And then the other thing that I did this last winter, and we'll be repeating this, is I had developed and taught a master's level class in medical device cybersecurity through the University of Minnesota's Technological Leadership Institute. And so after giving it once, they decided to make it a core curriculum for their medical device innovation. So it will be scheduled to be given annually. Things like the FDA keep coming out with new guidances, even while we were giving it last winter, one of the things that would happen each week is, this week, this got replaced. It's kind of this constantly changing environment that happens in this space. [00:25:13] Lindsey Dinneen: It keeps you on your toes and it keeps you learning and growing. I guess that's a great thing. [00:25:18] Ken Hoyme: I can't claim I've been bored. [00:25:22] Lindsey Dinneen: Brilliant. All right. Pivoting just for fun. Imagine someone were to offer you a million dollars to teach a masterclass on anything you want. It can be in your industry, but it doesn't have to be. What would you choose to teach and why? [00:25:37] Ken Hoyme: My first thought might be a master class in how to hide out with somebody's million dollars and not get caught. Being realistic, if I was teaching in my domain, I would probably want to expand out things related to security and safety and how that really is my technical expertise. If I was going to jump out of domain, you know, just something that, might seem off the wall would be a masterclass on the design and physics of the pipe organ. [00:26:09] Lindsey Dinneen: Oh, tell me more. [00:26:12] Ken Hoyme: When I was growing up, I studied the classical organ and sang in choir, was in the all state choir in high school and came out of high school thinking, music major, engineering, music, and I ultimately decided I could do music on an engineer's salary a lot easier than the other way around. And so I had twice been on pipe organ projects at churches I've attended where they brought in and bid and had a pipe organ builder install. So I've been close to that process. When I've been over in Europe, I seek organ recitals. So I've gotten to hear many instruments in Europe that are older than the United States. [00:27:00] And so, yeah, that's always been a passion and fascination of mine because there's such a engineering aspect of that and yet so much of it is musicality. And I've learned a lot interacting and talking with these builders. If I had a million bucks, I would be able to dive deeply into the topic and try to flesh out something that would actually be more comprehensive. [00:27:23] Lindsey Dinneen: Amazing. Okay. So I have to ask you, since you are a pipe organ enthusiast, how do you feel about the fact that there's quite a lot in pop culture of, it's being a vilified instrument, you know, you have the Phantom of the Opera, and there's like a Disney something that has a pipe organ that's a bad character. And how do you feel about the fact that pipe organs are used as villains? [00:27:48] Ken Hoyme: It's always an interesting thing when popular culture adapts something that is so much deeper. As a totally different but slight example, the accordion has always made fun of it. I don't remember how I tripped across it, but there is a very famous organ work by Olivier Messiaen, a French composer, which is-- I think it translates from French to English, "The Epiphany of the Lord." It is a multi-part work related to the Christmas story, and it is incredibly complex, somewhat challenging to listen to, you have to be quite into it. But there is a movement called Du Parmanu, which is, " God Descends and Becomes Us." And it is one of the most bombastic, just these big, huge chords. It's just exciting to hear. [00:28:40] And back 20 years ago, I heard or saw something about a Russian woman who had recorded the entire suite on accordion. And here in the Twin Cities, and it's nationally distributed, but I don't know how many different places, there's a gentleman by the name of Michael Barone who works for Minnesota Public Radio, who for 30 years plus has produced a weekly radio program called Pipe Dreams, all about the pipe organ and that. [00:29:10] So I ended up ordering, because I had a friend who was Russian and was only available on a Russian Amazon kind of equivalent, copies of it and sent a copy to Michael Barone and he actually played an excerpt. I think he did the Du Parmenu section on his radio program. And it's in countries like Russia, the accordion is treated very much differently than in Western countries, where it's more of a polka accompaniment. And so it's different instruments have the different faces, depending on how they're viewed and who's viewing them. So I just tend to look at the mass media view of it as the unwashed heathen. [00:29:48] That said, there is a woman who is bursting onto the scene, she's 26, I think, British, name is Anna Hapwood, and she has been making TikTok videos of her playing the organ, including at the, the Albert Great Hall that they do the BBC proms, and she is popularizing the instrument through her TikTok videos. I think it was CBS Sunday Morning, I saw her interviewed about how she's popularizing the instrument. You never know with the modern media and music distribution, how somebody might reinvigorate interest in something that was viewed as old fashioned before. [00:30:26] Lindsey Dinneen: Yeah, I love that. I love that. And I think it always depends on context. All sorts of instruments, for instance, could be used to be very light hearted and fun or very serious and mysterious. And part of it is just, yeah, are you playing in the major or minor keys? And, all the things that go into it. But anyway, it's just funny because pipe organ, I feel is one of those instruments that is a little polarizing [00:30:50] Ken Hoyme: I understand that. I was warped as a child and the interesting merging there is my father was a serial hobbyist. And when he went into a hobby, he went in 110%. And when I was growing up in my formative years, he was into gardening and breeding his own Asiatic lily types. And we had flowers everywhere and garden clubs would come through and tour the garden. [00:31:23] Then he went cold turkey on it and decided to build him an electronic organ in the basement and he built it from initially a kit and then through other designs that he did. And so I was in fifth or sixth grade with the soldering iron in my hand, helping build this electronic organ. And it was, part of what I view, my dad, his dad died in the Great Depression. He came out of World War II and really had to support his mother and sister, and never really had the money for college-- he would have been a great engineer-- but instead he manipulated my brother and I to both become electrical engineers, and part of it was by these, so part of my interest in organ was also my father's manipulation of getting my brother and I both interested in electrical engineering. [00:32:11] Lindsey Dinneen: Hey, it worked out. I love it. Okay. [00:32:14] Ken Hoyme: My brother has a church organ in his basement, so it took a little heavier with him than it did with me. I enjoy it being played but I don't play it myself anymore [00:32:22] Lindsey Dinneen: Ah, understandable. Well, what is one thing you wish to be remembered for after you leave this world? [00:32:24] Ken Hoyme: Number one would be that I didn't overstay my welcome. I would hope to be remembered that I made lives better, I made lives safer. That attention to detail matter and I worked on things that were significant, that actually had meaning for people's lives. When I moved from Honeywell to Guidant, I said, I used to be worrying on things that if they failed, people might die, 375 people at a time. And then you get into medical devices and now you're working to save their lives, one at a time. I would hope to be remembered that I worked to make a difference and had positive impact on people's lives. [00:33:03] Lindsey Dinneen: Yeah. Of course. Yeah. And then final question, what is one thing that makes you smile every time you see or think about it? [00:33:14] Ken Hoyme: I would have to say my children. Yep. I'm incredibly proud of them. They're both, both professionals, a dentist and an audiologist, they have remarkably snarky sense of humor that I presume they got from their mother. My story on that one was, I was telling my eldest one time, she said something snarky and I said, "Kirsten, you are the queen of snark." And her instant response was, "Yep, broke it, you bought it." But yeah, as you think about what you leave behind in the world, and I'm incredibly proud of them and the things that they've learned. They both secure, use individual passwords on every website and deal with the internet with the sufficient paranoia that they should, so I'm proud of that as well, but yeah. [00:33:57] Lindsey Dinneen: Excellent. Well, It sounds like you raised them right. [00:34:01] Ken Hoyme: They're great kids. They had to live with growing up with their dad being an engineer. [00:34:06] Lindsey Dinneen: Yeah. But it looks like it all worked out beautifully. So I'm very glad to hear all that. Ken, this has been so much fun. I really appreciate you joining me today. It was great to hear about your background and your advice, and I loved especially hearing about some of the little nuances that I wouldn't have gotten to otherwise, like pipe organ interests. So that's fantastic. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thanks so much for choosing that organization to support. And we just wish you continued success as you work to change lives for a better world. [00:34:54] Ken Hoyme: Thanks, Lindsey. I really enjoyed chatting with you. [00:34:57] Lindsey Dinneen: Yeah, same. And thank you so much to our listeners for tuning in. And if you're feeling as inspired as I am right now, I'd love it if you'd share this episode with a colleague or two, and we will catch you next time. [00:35:10] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.
Ken Riordan, Regulatory Affairs Project Manager at Telos Partners, brings a unique but essential perspective to his clients having worked in both the public and private sector. He was a lead reviewer for the FDA where he conducted scientific and engineering reviews of pre-market applications for cardiovascular devices. Ken's broad experience in the private sector with Bayer Pharmaceuticals, Philips Respironics and others enables him to apply creative and effective solutions to his clients. In this episode Ken shares what it was like to work at FDA, how reviewers are chosen, how collaboration within the agency works, what you should know about the three new Guidance's on the 510(k) process that were recently released, and how Telos Partners helps medical device companies.Links from this episode:Ken Riordan LinkedIn https://www.linkedin.com/in/ken-riordan/Telos Partners https://www.telospartnersllc.com/Support the showConnect with Mastering Medical Device: Website: https://www.masteringmedicaldevice.com LinkedIn: https://www.linkedin.com/company/mastering-medical-device Patrick Kothe LinkedIn: https://www.linkedin.com/in/patrick-kothe Patrick Kothe Twitter: https://twitter.com/patrickkothe Support the show for as little as $3/month: https://www.buzzsprout.com/1286645/support Thanks for listening!
Renzo Machini is a London-based partner at Fieldfisher's Data and Privacy team. He holds CIPP/E, CIPT and FIP certifications from the IAPP and is well versed in Cloud Computing, Big Data and other technologies overlapping with privacy and GDPR compliance. He has authored "Cloud Computing: A practical introduction to the legal issues" and, prior to becoming a solicitor, he worked for five years as a software engineer at Logica (now CGI), a major independent UK software house. With Renzo we are directly addressing the biggest elephant in the ePrivacy room today: What are the unintended consequences of the EDPB's recent Guidelines on the technical scope of article 5.3 of the ePrivacy Directive? References: Renzo Marchini on LinkedIn EDPB, Guidelines 2/2023 on Technical Scope of Art. 5(3) of ePrivacy Directive Renzo Marchini, “New Guidance released on the technical scope of Art 5(3) ePrivacy Directive - a landgrab by the EDPB” Renzo Marchini, “Cloud Computing: a practical introduction to the legal issues.” (Cambridge University Press).
Welcome to the weekly MormonNewsRoundup where Al & Dives ruminate on the great and spacious Beehive!
Show Information Dec 3, 2023 Greetings brothers and sisters! Welcome to the weekly MormonNewsRoundup. I am your humble host Dives, talent on loan from Kolob, My crew and I ruminate weekly on the great and spacious beehive! Thanks so much for joining us to discuss the latest current events in Mormondom. Full Title EP 91 - INSANE Mormon sexual abuse lawsuit, Tim Ballard and Sean Reyes sued, new guidance about stake organizations, and a day in the life of Susan's husband part 2! Welcome to the MormonNewsRoundup! Get to know Lila Who are you and what are you all about? Articles New lawsuit filed against Tim Ballard and Utah Attorney General Sean Reyes. https://x.com/adamherbets/status/1729223696056000612?s=46&t=Kn3MLSjDGf_9v6exU2J_Gg https://www.ksl.com/article/50801239/lawsuit-accuses-ag-sean-reyes-of-intimidating-critic-of-tim-ballard-our https://youtu.be/l-Kp2MLlK2A?si=pUPdrL4gX18gV10g https://x.com/thebookofevan/status/1729893000900133297?s=46&t=Kn3MLSjDGf_9v6exU2J_Gg Kevin Franke files for divorce, domestic relations injunction against wife Ruby amid child abuse allegations https://kutv.com/news/8-passengers-case/kevin-franke-files-for-divorce-domestic-violence-injunction-against-wife-ruby-franke-8-passengers-case-harassment-misuse-of-information-court-order-petition-jodi-hildebrandt-mormon-youtuber-child-abuse 8 Passengers case leads Utah lawmaker to argue for better overseeing of life coaches https://kutv.com/news/local/ruby-franke-case-leads-utah-lawmaker-to-argue-for-better-overseeing-of-life-coaches Lori Vallow Daybell https://www.ksl.com/article/50804859/new-details-on-how-deputies-moved-lori-vallow-daybell-from-idaho-to-arizona Residents sue over Heber Valley temple approval https://www.kpcw.org/wasatch-county/2023-11-30/residents-sue-wasatch-county-over-heber-valley-temple-approval Cody Wyoming Temple Update https://cowboystatedaily.com/2023/11/27/lds-church-doesnt-want-4-000-public-records-admitted-into-temple-lawsuit/ https://www.gillettenewsrecord.com/news/wyoming/article_ac845753-a317-51b2-ba03-46c77e2619ba.html PragerU asked who a modern prophet was, Latter-day Saints responded https://www.deseret.com/2023/11/27/23978109/what-is-a-prophet-lds-mormon https://x.com/_cultch/status/1729336251164086390?s=46&t=Kn3MLSjDGf_9v6exU2J_Gg Church launches 2023 Light the World Giving Machine campaign from Times Square https://www.thechurchnews.com/living-faith/2023/11/27/23979008/nativity-invitation-share-savior-light-christmas-reflected-times-square-billboards-new-york Parody Video Discussion Updated requirements to create a new ward or stake or to change unit boundaries. https://www.facebook.com/share/p/DDLj3Ms3hefVAAJg/?mibextid=WC7FNe Analysis Elder Bednar shares a day in the life of an Apostle, part 2 https://www.thechurchnews.com/leaders/2023/11/30/23981265/elder-bednar-shares-a-day-in-the-life-of-an-apostle-part-2 Video 10 best gift cards to give as Christmas presents https://www.deseret.com/2023/11/25/23966249/gift-card-christmas-gift https://www.cbssports.com/olympics/news/salt-lake-city-announced-as-preferred-host-for-2034-winter-olympics/ Poll of the Week Top 10 things the Church needs to do to prepare for the 2034 Olympics Connect with Dives! www.MormonNewsRoundup.org kolob@mormonnewsroundup.org Voicemail Twitter YouTube Instagram TikToc Facebook Support this Podcast Patreon New MNRU episodes live on YouTube Sundays at 9:30pm EST New MMR episodes live on YouTube Mondays at 9:30pm EST Shoutout to Weird Alma on bandcamp.com for this episode's music. Thanks so much for ruminating with us on the great and spacious beehive! And remember, remember: No unhallowed hand can stop this podcast from progressing! #lds, #mormon, #exmormon, #postmormon,#religion, #news, #ldschurch, #comeuntochrist, #churchofjesuschrist, #churchofjesuschristoflatterdaysaints, #byu, #byui, #josephsmith, #comefollowme, #polygamy, #bookofmormon, #becauseofhim, #hearhim --- Support this podcast: https://podcasters.spotify.com/pod/show/mormonnewsroundup/support
Jointly Provided by American Academy of CME and CheckRare CE Support for this accredited continuing education activity has been made possible through educational grant from Kyowa Kirin. Estimated time to complete: 0.25 hours Start date: November 30, 2023 End date: November 30, 2024 This 15-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster University, highlights the best practices to diagnose tumor induced osteomalacia (TIO) based on the recently published guidelines in the Journal of Internal Medicine. To earn credit, go to https://checkrare.com/learning/p-new-guidance-to-diagnose-tumor-induced-osteomalacia-tio-2023-2/Activity Faculty Aliya Khan MD, FRCPC, FACP, FACE, FASBMR Clinical Professor of Medicine Director, Calcium Disorders Clinic Director, Fellowship in Metabolic Bone Disease McMaster University Target Audience This activity has been designed to meet the educational needs of physicians specializing in neurology, orthopedics, internal medicine/general practice, rheumatology, endocrinology, pain management, and radiology, who may be involved in the care for individuals with TIO. Other healthcare providers may also participate. Learning Objectives After participating in the activity, learners should be better able to • Describe the latest recommendations for diagnosing patients with TIOAccreditation and Credit Designation In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physicians American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPs Other members of the care team will receive a certificate of participation. Disclosure Statement According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows: Faculty Educator Dr. Khan discloses the following relevant financial relationships with ineligible companies to disclose: • Advisory Board/Consultant: Amgen, Ascendis, Alexion • Grant/Research support: Ascendis, Alexion, Amolyt • Speakers Bureaus: Amgen, Ascendis, Alexion Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Method of Participation There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments at: https://checkrare.com/learning/p-new-guidance-to-diagnose-tumor-induced-osteomalacia-tio-2023-2/Your certificate will be emailed to you in within 30 days. Privacy For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ Contact For any questions, please contact: CEServices@academycme.org Copyright © 2023. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Jointly Provided by American Academy of CME and CheckRare CE Support for this accredited continuing education activity has been made possible through an educational grant from Kyowa Kirin. Estimated time to complete: 0.25 hours Start date: November 30, 2023 End date: November 30, 2024 This 15-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster University, highlights the best practices to diagnose tumor induced osteomalacia (TIO) based on the recently published guidelines in the Journal of Internal Medicine. To earn credit, go to https://checkrare.com/learning/p-new-guidance-to-treat-tumor-induced-osteomalacia-tio-2023-3/ Activity Faculty Aliya Khan MD, FRCPC, FACP, FACE, FASBMR Clinical Professor of Medicine Director, Calcium Disorders Clinic Director, Fellowship in Metabolic Bone Disease McMaster University Target Audience This activity has been designed to meet the educational needs of physicians specializing in neurology, orthopedics, internal medicine/general practice, rheumatology, endocrinology, pain management, and radiology, who may be involved in the care for individuals with TIO. Other healthcare providers may also participate. Learning Objectives After participating in the activity, learners should be better able to • Describe the latest recommendations for treating patients with TIOAccreditation and Credit Designation In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physicians American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPs Other members of the care team will receive a certificate of participation. Disclosure Statement According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows: Faculty Educator Dr. Khan discloses the following relevant financial relationships with ineligible companies to disclose: • Advisory Board/Consultant: Amgen, Ascendis, Alexion • Grant/Research support: Ascendis, Alexion, Amolyt • Speakers Bureaus: Amgen, Ascendis, Alexion Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Method of Participation There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments at: https://checkrare.com/learning/p-new-guidance-to-treat-tumor-induced-osteomalacia-tio-2023-3/Your certificate will be emailed to you in within 30 days. Privacy For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ Contact For any questions, please contact: CEServices@academycme.org Copyright © 2023. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Mike Resnick of Eversheds Sutherland discusses the effects on taxpayers of the corporate alternative minimum tax and its recently released guidance. For additional coverage, read these articles in Tax Notes:Proposed Regs for Corporate AMT Will Address Partnership SharesCorporate AMT Consolidation Rules Flow From Tax PrinciplesFinancial Firm Highlights Potential for Corporate AMT DistortionTreasury Official Explains Confusing Rule in Corporate AMT NoticeCorporate AMT Depreciation Tweaks Unsurprising but WelcomeGuidance Fills In Some Blanks on Corporate AMTFollow us on Twitter:David Stewart: @TaxStewTax Notes: @TaxNotes**This episode is sponsored by the University of California Irvine School of Law Graduate Tax Program. For more information, visit law.uci.edu/gradtax.This episode is sponsored by the Tax Attorney Recruiting Event. For more information, visit the-tare.com.***CreditsHost: David D. StewartExecutive Producers: Jasper B. Smith, Paige JonesShowrunner: Jordan ParrishAudio Engineers: Jordan Parrish, Peyton RhodesGuest Relations: Alexis Hart
Last month, the Office of Management and Budget issued guidance for federal agencies digital experience management — a policy that's been five years in the making as set out by the 21st Century Integrated Digital Experience Act. In her role as federal CIO, Clare Martorana is championing for progress in how agencies interact with the public online to make it easier for citizens to get the information, services or benefits they need in ways they expect. Martorana and Andy Lewandowski — senior adviser to the Federal CIO and director of the digital experience practice within the Office of the Federal CIO — join The Daily Scoop Podcast now to discuss the new policy and how they will oversee its roll out across government. The Daily Scoop Podcast is available every Tuesday and Thursday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast on Apple Podcasts, Google Podcasts, and Spotify.
John Byrne and Terry Pesce discuss the recent Interagency Guidance on Third-Party Relationships: Risk Management. They look at the implications of the guidance and what banks should do to assess their current risk management process for interactions with third parties.
US bank regulators have issued interagency guidance on third-party risk management. The new pronouncement combines and updates past guidance issued by the individual agencies. John and Elliot discuss key parts of the guidance and some implications for banks and their vendors.
See omnystudio.com/listener for privacy information.
© 2020-2025 Ivy Podcast Discovery LLC
